Clinical Trial Update: Immune Checkpoint Inhibitors (ICIs) Retreatment in Second-line Treatment of Advanced Gastric Cancer: a Retrospective, Real-world Study

View source ↗

Summary

A retrospective real-world study evaluating retreatment with immune checkpoint inhibitors as second-line therapy for advanced gastric cancer and gastroesophagea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Immune checkpoint inhibitors (immune checkpoint inhibitor)

Snippet

Sponsor: Yongxu Jia | Conditions: Gastric Cancer, Gastroesophageal Junction Cancer, Immune Checkpoint Inhibitors (ICIs) | Status: NOT_YET_RECRUITING